Kurzrock R - Search Results

1

The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care.

Reyes-Gibby CC, El Osta B, Spitz MR, Parsons H, Kurzrock R, Wu X, Shete S, Bruera E. Reyes-Gibby CC, et al. Among authors: kurzrock r. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3262-7. doi: 10.1158/1055-9965.EPI-08-0125. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18990769 Free PMC article.

2

Phase I study of a combination of recombinant tumor necrosis factor-alpha and recombinant interferon-gamma in cancer patients.

Kurzrock R, Feinberg B, Talpaz M, Saks S, Gutterman JU. Kurzrock R, et al. J Interferon Res. 1989 Aug;9(4):435-44. doi: 10.1089/jir.1989.9.435. J Interferon Res. 1989. PMID: 2502584

3

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.

Feinberg B, Kurzrock R, Talpaz M, Blick M, Saks S, Gutterman JU. Feinberg B, et al. Among authors: kurzrock r. J Clin Oncol. 1988 Aug;6(8):1328-34. doi: 10.1200/JCO.1988.6.8.1328. J Clin Oncol. 1988. PMID: 3411344

4

Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.

Wetzler M, Estrov Z, Talpaz M, Kim KJ, Alphonso M, Srinivasan R, Kurzrock R. Wetzler M, et al. Among authors: kurzrock r. Cancer Res. 1994 Apr 1;54(7):1837-42. Cancer Res. 1994. PMID: 8137298

5

Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.

Kurzrock R, Redman J, Cabanillas F, Jones D, Rothberg J, Talpaz M. Kurzrock R, et al. Cancer Res. 1993 May 1;53(9):2118-22. Cancer Res. 1993. PMID: 8481913

6

Cytokine deregulation in hematological malignancies: clinical and biological implications.

Kurzrock R. Kurzrock R. Clin Cancer Res. 1997 Dec;3(12 Pt 2):2581-4. Clin Cancer Res. 1997. PMID: 9815659 Review.

7

The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.

Ferrajoli A, Keating MJ, Manshouri T, Giles FJ, Dey A, Estrov Z, Koller CA, Kurzrock R, Thomas DA, Faderl S, Lerner S, O'Brien S, Albitar M. Ferrajoli A, et al. Among authors: kurzrock r. Blood. 2002 Aug 15;100(4):1215-9. Blood. 2002. PMID: 12149200 Free article.

8

Interleukin-6 and its receptor in cancer: implications for translational therapeutics.

Hong DS, Angelo LS, Kurzrock R. Hong DS, et al. Among authors: kurzrock r. Cancer. 2007 Nov 1;110(9):1911-28. doi: 10.1002/cncr.22999. Cancer. 2007. PMID: 17849470 Free article. Review.

9

Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/C and IL8-251T/A.

Reyes-Gibby CC, Spitz M, Wu X, Merriman K, Etzel C, Bruera E, Kurzrock R, Shete S. Reyes-Gibby CC, et al. Among authors: kurzrock r. Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2745-51. doi: 10.1158/1055-9965.EPI-07-0651. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18086782

10

Phase II trial of curcumin in patients with advanced pancreatic cancer.

Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Dhillon N, et al. Among authors: kurzrock r. Clin Cancer Res. 2008 Jul 15;14(14):4491-9. doi: 10.1158/1078-0432.CCR-08-0024. Clin Cancer Res. 2008. PMID: 18628464 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,016 results

Search Page

Filters